Appendix 3Y - David Fenlon
Released
Released
Announcement PDF
Appendix 3Y
Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity:
Elixinol Wellness Limited
ABN:
621 479 794
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for
the director for the purposes of section 205G of the Corporations Act.
Name of Director
David Fenlon
Date of last notice
31 May 2023
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should
be disclosed in this part.
Direct or indirect interest
Direct
Nature of indirect interest
(including registered holder)
N/A
Note: Provide details of the circumstances giving rise to the relevant
interest.
Date of change
31 August 2023
No. of securities held prior to change
465,753 Performance Share Rights
2,500,000 Director Fee rights
Class
1)
2)
Number acquired
Number disposed
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
3)
Fully paid ordinary shares
Unlisted options with an exercise
price of $0.02 expiring on 31 August
2025
Director Fee rights
1)
2)
3)
1)
2)
3)
625,000
625,000
Nil
Nil
Nil
625,000
Appendix 3Y
Change of Director’s Interest Notice
Value/Consideration
Note: If consideration is non-cash, provide details and estimated
valuation
Nil financial consideration
vesting of Director Fee rights.
paid
on
No. of securities held after change
625,000 Fully paid ordinary shares
465,753 Performance Share Rights
1,875,000 Director Fee rights
625,000 Unlisted options
Nature of change
Issue of fully paid ordinary shares and
unlisted options on vesting of Director
Fee rights
Example: on-market trade, off-market trade, exercise of options,
issue of securities under dividend reinvestment plan, participation in
buy-back
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should
be disclosed in this part.
Detail of contract
N/A
Nature of interest
N/A
Name of registered holder
(if issued securities)
N/A
Date of change
N/A
No. and class of securities to which N/A
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired
N/A
Interest disposed
N/A
Value/Consideration
N/A
Note: If consideration is non-cash, provide details
and an estimated valuation
Interest after change
N/A
Part 3 – +Closed period
Were the interests in the securities or contracts detailed No
above traded during a +closed period where prior written
clearance was required?
If so, was prior written clearance provided to allow the trade N/A
to proceed during this period?
+ See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Appendix 3Y
Change of Director’s Interest Notice
If prior written clearance was provided, on what date was this N/A
provided?
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3
Share your feedback
Discover